Reactive Carbonyl Species: Diabetic Complication in the Heart and Lungs

Trends Endocrinol Metab. 2019 Aug;30(8):546-556. doi: 10.1016/j.tem.2019.05.005. Epub 2019 Jun 25.

Abstract

Abnormal chemical reactions in hyperglycemia alter normal metabolic processes in diabetes, which is a key process in the production of reactive carbonyls species (RCS). Increasing the concentration of RCS may result in carbonyl/oxidative stress in both the diabetic heart and lung. Ryanodine receptors (RyRs) not only play a key role in heart contraction, including rhythmic contraction and relaxation of the heart, but they are also important for controlling the airway smooth muscle. RCS modifies RyRs, resulting in RyRs dysfunction, which is involved in important mechanisms in diabetic complications. Very little is known about the mechanistic relationship between the heart and lung in diabetes. This review highlights new findings on the pathophysiological mechanisms and discusses potential approaches to treatment for these complications.

Keywords: diabetes heart disease; diabetes lung disease; reactive carbonyl species; ryanodine receptor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diabetes Complications / metabolism*
  • Humans
  • Lung / metabolism*
  • Myocardium / metabolism*
  • Ryanodine Receptor Calcium Release Channel / metabolism

Substances

  • Ryanodine Receptor Calcium Release Channel